Jagsonpal Pharmaceuticals
JAGSNPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: R P S Kochhar · MD: R P S Kochhar · Listing date: Sept. 12, 1996 · New Delhi · http://www.jagsonpal.com

Stock Price vs Company Growth
1d
2.3%
1w
1.1%
1m
0.6%
3m
7.3%
6m
37.6%
1y
22.7%
5y
27.5%
10y
32.2%
all
20.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 224 2.3%
196
265
Company Overview

Sales
287 Cr
Growth: 7.9%
Profit after Tax
43.1 Cr
Growth: 5.3%
Small Cap
1,477 Cr
P/E: 35.5x
Industry P/E: 32.3x
Fundamentals

Sales (Cr) ₹ 287
Growth 7.9%
EBITDA 20.2%
P/S 5.1x
Dividend 1.0%
P/E 35.5x
Book Value ₹ 41.9
PEG Ratio 4.5x
ROE 16.2%
P/B 5.4x
Shareholding Pattern

Institutions
Promoters
Aresko Progressive Private Limited
65.71 %
Rajpal Singh Kochhar
4.63 %
Others
Investor Education And Protection Fund Authority
1.56 %
Sanjiv Kumar Dudeja
1.41 %
Lincoln P Coelho
1.16 %
Increase    Decrease    No change
Company Profile Detailed

In 1964 Jagsonpal started from humble beginnings with Jagmohan S. Kochhar operating a chemists shop in Delhi. Soon he expanded into making formulations. Mr. Kochhar’s vision was to spread health and healing in India on a larger scale. He was at the helm of the company from its inception, through the startup phase. Even though Jagsonpal was a small business at the time, his vision was to create one of India’s premiere pharmaceutical companies.
Investors (24)
Followers (1)